Skip to main content
. Author manuscript; available in PMC: 2020 Jul 31.
Published in final edited form as: Pediatr Cardiol. 2020 Apr 30;41(5):972–978. doi: 10.1007/s00246-020-02345-8

Table 3.

Postnatal outcomes

Outcomes <37 weeks (N = 55) ≥37 weeks (N = 182) P value 37–38 weeks (N = 59) 39–40 weeks (N = 123) P value
n (percent)

Sex
 Male 26 (49.1) 96 (53.0) 0.72 30 (50.8) 66 (54.1) 0.8
 Female 27 (50.9) 85 (47.0) 29 (49.2) 56 (45.9)
Weight <2500 g 38 (73.1) 13 (7.2) <0.001 12 (20.3) 1 (0.8) <0.001
Cord arterial pH <7.10 5 (16.7) 0 (0.0) 0.001 0 (0.0) 0 (0.0)
NICU support
 Intubation 24 (45.3) 66 (36.5) 0.26 28 (47.5) 38 (31.1) 0.049
 HFOV 11 (45.8) 8 (12.1) 0.002 5 (17.9) 3(7.9) 0.27
 Nitric osride 6(11.3) 14 (7.7) 0.41 4 (6.8) 10 (8.2) 0.99
 Vasopressors 16 (30.2) 43 (23.8) 0.37 20 (33.9) 23 (18.9) 0.04
 Prostaglandin 18 (34.0) 83 (45.9) 0.16 37 (62.7) 46 (37.7) 0.003
 Antibiotics 34 (64.2) 79 (43.6) 0.01 34 (57.6) 45 (36.9) 0.01
ECMO 2 (3.6) 10 (5.5) 0.74 2 (3.4) 8 (6.5) 0.5
Hospital length of stay (days), median (range) 18 (1,294) 16 (1,630) 0.56 24 (2, 630) 13 (1, 173) 0.001
Age at 1st cardiac surgery (days), medias (range) 29 (2,1095) 7 (1,540) 0.002 8 (1,510) 7 (1,540) 0.86

NICU neonatal intensive care unit, HFOV high-frequency oscillatory ventilation, ECMO extracorporeal membrane oxygenation

P value is for χ2 test or Fisher’s exact test for categorical variables or Student’s t-tests or Wilcoxon rank-sum tests for continuous variables